Phenytoin Induced Drug Rash with Eosinophilia and Systemic Symptoms: A rare paediatric case report
Abstract
Purpose: Dress Syndrome (Drug rash with eosinophilia and systemic symptoms) is a severe adverse drug reaction characterised by rash, fever, lymphadenopathy, and organ involvement. It is a severe, one-of-a-kind adverse medication reaction. DRESS is the most rarely seen severe adverse drug reaction, and it affects approximately 1 in a thousand to 1 in a ten thousand patients who take the drug. It is found that the mortality rate is nearly 10 %. The main objectives include - learn the importance of DRESS syndrome, recognize the signs and symptoms of DRESS, to know what diagnostic studies are indicated and to provide accurate treatment.
Methods: The case of 11-year-old girl who came with history of head injury and was given phenytoin to treat it. Later she came with a complaint of numerous urticated papules and plaques on her trunk, neck, both upper and lower limbs, and febrile since 4days. And we used the Regi SCAR scoring system that grades DRESS cases as ‘no’, ‘possible’, ‘probable’ or ‘definite’ groups for diagnostic criteria of DRESS. And we also applied Naranjo’s causality assessment scale in the following case study.
Results and conclusion: In the initial recognition of DRESS syndrome and the immediate withdrawal of offending drugs and continuing with a supportive therapy and corticosteroids as needed. Systemic corticosteroids can reduce symptoms of hypersensitivity reactions.
Keywords: Drug Reaction with Eosinophilia and Systemic Symptoms, Phenytoin, Exfoliation of Skin, Corticosteroids.
Keywords:
Drug Reaction with Eosinophilia and Systemic Symptoms, Phenytoin, Exfoliation of Skin, CorticosteroidsDOI
https://doi.org/10.22270/jddt.v12i2-S.5416References
Deka, N.M., Dass, R., Das, B.K. et al. Phenytoin Induced DRESS Syndrome. Indian J Pediatr 2013; 80:266. https://doi.org/10.1007/s12098-012-0751-7
Kim C, Choi G, Yun C, Kim D. Drug Hypersensitivity to Previously Tolerated Phenytoin by Carbamazepine-induced DRESS Syndrome. Journal of Korean Medical Science. 2006; 21(4):768. https://doi.org/10.3346/jkms.2006.21.4.768
Criado P, Criado R, Avancini J, Santi C. Drug reaction with Eosinophilia and Systemic Symptoms (DRESS) / Drug-induced Hypersensitivity Syndrome (DIHS): a review of current concepts. Anais Brasileiros de Dermatologia. 2012; 87(3):435-449. https://doi.org/10.1590/S0365-05962012000300013
Oliveira A, Carvalho R, Martins A, Reis J. Acute Hepatitis in the DRESS Syndrome. GE Portuguese Journal of Gastroenterology. 2016; 23(6):304-308. https://doi.org/10.1016/j.jpge.2016.06.001
Cacoub P, Musette P, Descamps V, Meyer O, Speirs C, Finzi L et al. The DRESS Syndrome: A Literature Review. The American Journal of Medicine. 2011; 124(7):588-597. https://doi.org/10.1016/j.amjmed.2011.01.017
Mori F, Caffarelli C, Caimmi S, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS) in children. Acta Biomed. 2019; 90(3-S):66-79. Published 2019 Jan 29. https://doi.org/10.23750/abm.v90i3-S.8167
Oelze L, Pillow M. Phenytoin-induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome: A Case Report from the Emergency Department. The Journal of Emergency Medicine. 2013; 44(1):75-78. https://doi.org/10.1016/j.jemermed.2011.05.052
I J, P O. Possible DRESS Syndrome in a Patient with Systemic Sclerosis and Rheumatoid Arthritis during Treatment with Lamotrigine. Archives of Medicine. 2018; 10(6). https://doi.org/10.21767/1989-5216.1000288
Jihana S, Parathoduvil AA, Purushothaman S. "An analysis of seriousness, predictability and preventability of adverse drug reactions reported at a tertiary care teaching hospital in Kerala, India: a retrospective observational record based study." International Journal of Basic & Clinical Pharmacology [Online], 2018; 7(12):2433-2438.
De A, Rajagopalan M, Sarda A, Das S, Biswas P. Drug reaction with eosinophilia and systemic symptoms: An update and review of recent literature. Indian Journal of Dermatology. 2018; 63(1):30. https://doi.org/10.4103/ijd.IJD_582_17
Published
Abstract Display: 530 
PDF Downloads: 896 PDF Downloads: 134 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.